In conclusion, we here report six new distinct CpG methylation targets (L3MBTL1, NKX6-2, PREX1, TRAF7, PRDM14, and NEFM) in African Americans with CRC. This evidence concerns the gene L3MBTL1 and colorectal carcinoma.